Exploring the frontier in robotic pediatric cancer surgery: when to move forward and when to stop
Topic overview
Retrospective analysis of 38 pediatric cancer patients undergoing robotic-assisted tumor resection shows safety and efficacy despite 31.58% open conversion rate, primarily due to vascular challenges. All patients resumed chemotherapy on schedule with low complication rates, emphasizing importance of patient selection and technical expertise during learning curve.
Key takeaways
- Robotic-assisted tumor resection is safe and effective in pediatric oncology, even during the learning curve phase with proper patient selection.
- Vascular challenges were the primary reason for open conversion (23.68% of cases), highlighting the need for careful preoperative vascular assessment.
- Neuroblastoma was the most common indication (n=19), with adrenalectomy being the predominant procedure (28.94% of cases).
- All patients resumed scheduled postoperative chemotherapy without delay, demonstrating minimal impact on oncologic treatment protocols.
- Multidisciplinary tumor board discussion and careful consideration of tumor characteristics are critical for successful robotic case selection.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Exploring the frontier in robotic pediatric cancer surgery: when to move forward and when to stop. GlobalCastMD Medical Library. 2024-05-28. https://dev.library.globalcastmd.com/article/8665?via_space=staycurrentmd
Comments